{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T20:03:00Z","timestamp":1750708980503,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971547","81900136"],"award-info":[{"award-number":["81971547","81900136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Hospitals Authority\u2019s Ascent Plan","award":["DFL20221001"],"award-info":[{"award-number":["DFL20221001"]}]},{"name":"National Key Research and Development Program of China","award":["2021YFC2702005"],"award-info":[{"award-number":["2021YFC2702005"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-03-53"],"award-info":[{"award-number":["320.6750.2022-03-53"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s12519-023-00729-3","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T13:10:50Z","timestamp":1683551450000},"page":"687-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China"],"prefix":"10.1007","volume":"19","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Xin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Wei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"729_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fimmu.2012.00265","volume":"3","author":"AV Sauer","year":"2012","unstructured":"Sauer AV, Brigida I, Carriglio N, Aiuti A. Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. Front Immunol. 2012;3:265.","journal-title":"Front Immunol"},{"key":"729_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.iac.2010.01.002","volume":"30","author":"HB Gaspar","year":"2010","unstructured":"Gaspar HB. Bone marrow transplantation and alternatives for adenosine deaminase deficiency. Immunol Allergy Clin North Am. 2010;30:221\u201336.","journal-title":"Immunol Allergy Clin North Am"},{"key":"729_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/scitranslmed.3002594","volume":"3","author":"KL Shaw","year":"2011","unstructured":"Shaw KL, Kohn DB. A tale of two SCIDs. Sci Transl Med. 2011;3:97\u201336.","journal-title":"Sci Transl Med"},{"key":"729_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13023-018-0807-5","volume":"13","author":"AM Flinn","year":"2018","unstructured":"Flinn AM, Gennery AR. Adenosine deaminase deficiency: a review. Orphanet J Rare Dis. 2018;13:65\u20137.","journal-title":"Orphanet J Rare Dis"},{"key":"729_CR5","unstructured":"Hershfield M. Adenosine Deaminase Deficiency. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993\u20132023."},{"key":"729_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","volume":"2","author":"ER Giblett","year":"1972","unstructured":"Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972;2:1067\u20139.","journal-title":"Lancet"},{"key":"729_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ped4.12183","volume":"4","author":"Q Sun","year":"2020","unstructured":"Sun Q, Guo J, Hao C, Guo R, Hu X, Chen Y, et al. Whole-exome sequencing reveals two de novo variants in the RBM20 gene in two Chinese patients with left ventricular non-compaction cardiomyopathy. Pediatr Investig. 2020;4:11\u20136.","journal-title":"Pediatr Investig"},{"key":"729_CR8","first-page":"87","volume":"24","author":"XM Lu","year":"1989","unstructured":"Lu XM, Zhu CJ, Zhang XZ, Liu HQ, Sun RP. A case of combined immunodeficiency with adenine deaminase deficiency. J Shandong Univ. 1989;24:87\u20138 (in Chinese).","journal-title":"J Shandong Univ"},{"key":"729_CR9","first-page":"636","volume":"56","author":"WL Liang","year":"2018","unstructured":"Liang WL, Liu CJ, Wu Q, Liu YL, Mao HW. A case of adenosine deaminase deficiency caused by new gene mutation. Chin J Pediatr. 2018;56:636\u20137 (in Chinese).","journal-title":"Chin J Pediatr"},{"key":"729_CR10","first-page":"877","volume":"27","author":"T Li","year":"2020","unstructured":"Li T, Lu G, Tao JP, Huang L. A case of severe combined immunodeficiency caused by adenosine deaminase deficiency. Chin Pediatr Emerg. 2020;27:877\u20138 (in Chinese).","journal-title":"Chin Pediatr Emerg"},{"key":"729_CR11","first-page":"988","volume":"37","author":"J Guan","year":"2021","unstructured":"Guan J, Hu Q, Wang L, Zhang T, Cheng H, Zou L. A new ADA gene complex heterozygous mutation causes late onset atypical severe combined immunodeficiency disease. Immunol J. 2021;37:988\u201394.","journal-title":"Immunol J"},{"key":"729_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1086\/302054","volume":"63","author":"FX Arredondo-Vega","year":"1998","unstructured":"Arredondo-Vega FX, Santisteban I, Daniels S, Toutain S, Hershfield MS. Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am J Hum Genet. 1998;63:1049\u201359.","journal-title":"Am J Hum Genet"},{"key":"729_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1172\/JCI113909","volume":"83","author":"R Hirschhorn","year":"1989","unstructured":"Hirschhorn R, Tzall S, Ellenbogen A, Orkin SH. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency. J Clin Invest. 1989;83:497\u2013501.","journal-title":"J Clin Invest"},{"key":"729_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s12185-012-1055-4","volume":"95","author":"H Nakaoka","year":"2012","unstructured":"Nakaoka H, Kanegane H, Taneichi H, Miya K, Yang X, Nomura K, et al. Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis. Int J Hematol. 2012;95:692\u20136.","journal-title":"Int J Hematol"},{"key":"729_CR15","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1093\/hmg\/4.11.2081","volume":"4","author":"I Santisteban","year":"1995","unstructured":"Santisteban I, Arredondo-Vega FX, Kelly S, Loubser M, Meydan N, Roifman C, et al. Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum Mol Genet. 1995;4:2081\u20137.","journal-title":"Hum Mol Genet"},{"key":"729_CR16","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/bib\/bbz047","volume":"21","author":"N Cheng","year":"2020","unstructured":"Cheng N, Li M, Zhao L, Zhang B, Yang Y, Zheng CH, et al. Comparison and integration of computational methods for deleterious synonymous mutation prediction. Brief Bioinform. 2020;21:970\u201381.","journal-title":"Brief Bioinform"},{"key":"729_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tig.2014.04.006","volume":"30","author":"RC Hunt","year":"2014","unstructured":"Hunt RC, Simhadri VL, Iandoli M, Sauna ZE, Kimchi-Sarfaty C. Exposing synonymous mutations. Trends Genet. 2014;30:308\u201321.","journal-title":"Trends Genet"},{"key":"729_CR18","doi-asserted-by":"publisher","first-page":"13574","DOI":"10.1371\/journal.pone.0013574","volume":"5","author":"R Chen","year":"2010","unstructured":"Chen R, Davydov EV, Sirota M, Butte AJ. Nonsynonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association. PLoS One. 2010;5:13574.","journal-title":"PLoS ONE"},{"key":"729_CR19","first-page":"102173","volume":"24","author":"J Niersch","year":"2021","unstructured":"Niersch J, Vega-Rubin-de-Celis S, Bazarna A, Mergener S, Jendrossek V, Siveke JT, et al. A BAP1 synonymous mutation results in exon skipping loss of function and worse patient prognosis. Science. 2021;24:102173.","journal-title":"Science"},{"key":"729_CR20","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1016\/j.ygeno.2020.06.024","volume":"112","author":"M Li","year":"2020","unstructured":"Li M, Lu X, Dong J, Yao Z, Wu Y, Rao H, et al. A synonymous mutation in exon 39 of FBN1 causes exon skipping leading to Marfan syndrome. Genomics. 2020;112:3856\u201361.","journal-title":"Genomics"},{"key":"729_CR21","doi-asserted-by":"publisher","first-page":"7689","DOI":"10.1073\/pnas.1707741114","volume":"114","author":"K Ito","year":"2017","unstructured":"Ito K, Patel PN, Gorham JM, McDonough B, DePalma SR, Adler EE, et al. Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. Proc Natl Acad Sci U S A. 2017;114:7689\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"729_CR22","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/humu.24246","volume":"42","author":"R Zhang","year":"2021","unstructured":"Zhang R, Chen Z, Song Q, Wang S, Liu Z, Zhao X, et al. Identification of seven exonic variants in the SLC4A1, ATP6V1B1, and ATP6V0A4 genes that alter RNA splicing by minigene assay. Hum Mutat. 2021;42:1153\u201364.","journal-title":"Hum Mutat"},{"key":"729_CR23","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1086\/302418","volume":"64","author":"SN Teraoka","year":"1999","unstructured":"Teraoka SN, Telatar M, Becker-Catania S, Liang T, Onengut S, Tolun A, et al. Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet. 1999;64:1617\u201331.","journal-title":"Am J Hum Genet"},{"key":"729_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s10875-018-0496-9","volume":"38","author":"D Cagdas","year":"2018","unstructured":"Cagdas D, Gur Cetinkaya P, Karaatmaca B, Esenboga S, Tan C, Y\u0131lmaz T, et al. ADA deficiency: evaluation of the clinical and laboratory features and the outcome. J Clin Immunol. 2018;38:484\u201393.","journal-title":"J Clin Immunol"},{"key":"729_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.drudis.2014.02.010","volume":"19","author":"L Antonioli","year":"2014","unstructured":"Antonioli L, Cs\u00f3ka B, Fornai M, Colucci R, K\u00f3kai E, Blandizzi C, et al. Adenosine and inflammation: what\u2019s new on the horizon? Drug Discov Today. 2014;19:1051\u201368.","journal-title":"Drug Discov Today"},{"key":"729_CR26","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1182\/blood-2008-02-136325","volume":"112","author":"SV Novitskiy","year":"2008","unstructured":"Novitskiy SV, Ryzhov S, Zaynagetdinov R, Goldstein AE, Huang Y, Tikhomirov OY, et al. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood. 2008;112:1822\u201331.","journal-title":"Blood"},{"key":"729_CR27","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1096\/fj.11-200907","volume":"26","author":"H Karmouty Quintana","year":"2012","unstructured":"Karmouty Quintana H, Zhong H, Acero L, Weng T, Melicoff E, West JD, et al. The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. FASEB J. 2012;26:2546\u201357.","journal-title":"FASEB J"},{"key":"729_CR28","doi-asserted-by":"publisher","first-page":"1562973","DOI":"10.1155\/2020\/1562973","volume":"2020","author":"L Huang","year":"2020","unstructured":"Huang L, Fan J, Chen Y, Wang J. Inhibition of A2B adenosine receptor attenuates intestinal injury in a rat model of necrotizing enterocolitis. Mediators Inflamm. 2020;2020:1562973.","journal-title":"Mediators Inflamm"},{"key":"729_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2016.11.024","volume":"117","author":"S Merighi","year":"2017","unstructured":"Merighi S, Bencivenni S, Vincenzi F, Varani K, Borea PA, Gessi S. A2B adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway. Pharmacol Res. 2017;117:9\u201319.","journal-title":"Pharmacol Res"},{"key":"729_CR30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3390\/molecules26041188","volume":"26","author":"G Marucci","year":"2021","unstructured":"Marucci G, Ben DD, Lambertucci C, Navia AM, Spinaci A, Volpini R, et al. Combined therapy of A1AR agonists and A2AAR antagonists in neuroinflammation. Molecules. 2021;26:1188.","journal-title":"Molecules"},{"key":"729_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38:569\u201378.","journal-title":"J Clin Immunol"},{"key":"729_CR32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911\u201320.","journal-title":"N Engl J Med"},{"key":"729_CR33","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370:921\u201331.","journal-title":"N Engl J Med"},{"key":"729_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00281-022-00918-8","volume":"44","author":"PY Lee","year":"2022","unstructured":"Lee PY, Aksentijevich I, Zhou Q. Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2). Semin Immunopathol. 2022;44:269\u201380.","journal-title":"Semin Immunopathol"},{"key":"729_CR35","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","volume":"74","author":"Y Kaljas","year":"2017","unstructured":"Kaljas Y, Liu C, Skaldin M, Wu C, Zhou Q, Lu Y, et al. Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci. 2017;74:555\u201370.","journal-title":"Cell Mol Life Sci"},{"key":"729_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/eji.202048549","volume":"51","author":"F Schena","year":"2021","unstructured":"Schena F, Penco F, Volpi S, Pastorino C, Caorsi R, Kalli F, et al. Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients. Eur J Immunol. 2021;51:206\u201319.","journal-title":"Eur J Immunol"},{"key":"729_CR37","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s10875-021-01141-0","volume":"41","author":"JY Yap","year":"2021","unstructured":"Yap JY, Moens L, Lin M, Kane A, Kelleher A, Toong C, et al. Intrinsic defects in B cell development and differentiation, T cell exhaustion and altered unconventional T cell generation characterize human adenosine deaminase type 2 deficiency. J Clin Immunol. 2021;41:1915\u201335.","journal-title":"J Clin Immunol"},{"key":"729_CR38","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4049\/jimmunol.155.2.536","volume":"155","author":"P Benveniste","year":"1995","unstructured":"Benveniste P, Zhu W, Cohen A. Interference with thymocyte differentiation by an inhibitor of S-adenosylhomocysteine hydrolase. J Immunol. 1995;155:536\u201344.","journal-title":"J Immunol"},{"key":"729_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1172\/JCI4320","volume":"103","author":"L Gangi-Peterson","year":"1999","unstructured":"Gangi-Peterson L, Sorscher DH, Reynolds JW, Kepler TB, Mitchell BS. Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination. J Clin Invest. 1999;103:833\u201341.","journal-title":"J Clin Invest"},{"key":"729_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI200110360","volume":"108","author":"SG Apasov","year":"2001","unstructured":"Apasov SG, Blackburn MR, Kellems RE, Smith PT, Sitkovsky MV. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J Clin Invest. 2001;108:131\u201341.","journal-title":"J Clin Invest"},{"key":"729_CR41","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.4049\/jimmunol.171.10.5562","volume":"171","author":"MB Aldrich","year":"2003","unstructured":"Aldrich MB, Chen W, Blackburn MR, Martinez-Valdez H, Datta SK, Kellems RE. Impaired germinal center maturation in adenosine deaminase deficiency. J Immunol. 2003;171:5562\u201370.","journal-title":"J Immunol"},{"key":"729_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/cmi.2012.43","volume":"10","author":"J Zheng","year":"2013","unstructured":"Zheng J, Liu Y, Lau Y, Tu W. \u03b3\u03b4-T cells: an unpolished sword in human anti-infection immunity. Cell Mol Immunol. 2013;10:50\u20137.","journal-title":"Cell Mol Immunol"},{"key":"729_CR43","doi-asserted-by":"publisher","first-page":"e002274","DOI":"10.1136\/jitc-2020-002274","volume":"9","author":"L Ou","year":"2021","unstructured":"Ou L, Wang H, Liu Q, Zhang J, Lu H, Luo L, et al. Dichotomous and stable gamma delta T-cell number and function in healthy individuals. J Immunother Cancer. 2021;9:e002274.","journal-title":"J Immunother Cancer"},{"key":"729_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s10875-022-01375-6","volume":"43","author":"EA Tuovinen","year":"2023","unstructured":"Tuovinen EA, P\u00f6ysti S, Hamdan F, Le KM, Keskitalo S, Turunen T, et al. Characterization of expanded gamma delta T cells from atypical X-SCID patient reveals preserved function and IL2RG-mediated signaling. J Clin Immunol. 2023;43:358\u201370.","journal-title":"J Clin Immunol"},{"key":"729_CR45","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jaci.2013.10.002","volume":"133","author":"B Garcillan","year":"2014","unstructured":"Garcillan B, Mazariegos MS, Fisch P, Res PC, Mu\u00f1oz-Ruiz M, Gil J, et al. Enrichment of the rare CD4+ \u03b3\u03b4 T-cell subset in patients with atypical CD3\u03b4 deficiency. J Allergy Clin Immunol. 2014;133:1205\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"729_CR46","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1172\/JCI25221","volume":"115","author":"S Ehl","year":"2005","unstructured":"Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, K\u00fchr J, et al. A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest. 2005;115:3140\u20138.","journal-title":"J Clin Invest"},{"key":"729_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clim.2018.11.006","volume":"201","author":"I Tometten","year":"2019","unstructured":"Tometten I, Felgentreff K, H\u00f6nig M, Hauck F, Albert MH, Niehues T, et al. Increased proportions of \u03b3\u03b4 T lymphocytes in atypical SCID associate with disease manifestations. Clin Immunol. 2019;201:30\u20134.","journal-title":"Clin Immunol"},{"key":"729_CR48","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41577-020-0345-y","volume":"20","author":"DG Pellicci","year":"2020","unstructured":"Pellicci DG, Koay HF, Berzins SP. Thymic development of unconventional T cells: how NKT cells, MAIT cells and \u03b3\u03b4 T cells emerge. Nat Rev Immunol. 2020;20:756\u201370.","journal-title":"Nat Rev Immunol"},{"key":"729_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jaci.2018.04.029","volume":"143","author":"VH Kim","year":"2019","unstructured":"Kim VH, Pham-Huy A, Grunebaum E. Neutropenia among patients with adenosine deaminase deficiency. J Allergy Clin Immunol. 2019;143:403\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"729_CR50","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1182\/blood-2009-03-209221","volume":"114","author":"AV Sauer","year":"2009","unstructured":"Sauer AV, Mrak E, Jofra Hernandez R, Zacchi E, Cavani F, Casiraghi M, et al. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL\/OPG imbalance and osteoblast insufficiency. Blood. 2009;114:3216\u201326.","journal-title":"Blood"},{"key":"729_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jpeds.2003.10.055","volume":"144","author":"W Albuquerque","year":"2004","unstructured":"Albuquerque W, Gaspar HB. Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency. J Pediatr. 2004;144:278\u201380.","journal-title":"J Pediatr"},{"key":"729_CR52","doi-asserted-by":"publisher","first-page":"40136","DOI":"10.1038\/srep40136","volume":"7","author":"AV Sauer","year":"2017","unstructured":"Sauer AV, Hernandez RJ, Fumagalli F, Bianchi V, Poliani PL, Dallatomasina C, et al. Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients. Sci Rep. 2017;7:40136.","journal-title":"Sci Rep"},{"key":"729_CR53","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10875-012-9658-3","volume":"32","author":"C Booth","year":"2012","unstructured":"Booth C, Algar VE, Xu-Bayford J, Fairbanks L, Owens C, Gaspar HB. Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency. J Clin Immunol. 2012;32:449\u201353.","journal-title":"J Clin Immunol"},{"key":"729_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-0030-1269916","volume":"223","author":"JS K\u00fchl","year":"2011","unstructured":"K\u00fchl JS, Schwarz K, M\u00fcnch A, Schmugge M, Pekrun A, Meisel C, et al. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID). Klin Padiatr. 2011;223:85\u20139.","journal-title":"Klin Padiatr"},{"key":"729_CR55","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s10875-015-0158-0","volume":"35","author":"O Nikolajeva","year":"2015","unstructured":"Nikolajeva O, Worth A, Hague R, Martinez-Alier N, Smart J, Adams S, et al. Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome. J Clin Immunol. 2015;35:366\u201372.","journal-title":"J Clin Immunol"},{"key":"729_CR56","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jaci.2011.10.028","volume":"129","author":"C Kesserwan","year":"2012","unstructured":"Kesserwan C, Sokolic R, Cowen EW, Garabedian E, Heselmeyer-Haddad K, Lee CCR, et al. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J Allergy Clin Immunol. 2012;129:762\u20139.e1.","journal-title":"J Allergy Clin Immunol"},{"key":"729_CR57","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s10875-021-01018-2","volume":"41","author":"AM Flinn","year":"2021","unstructured":"Flinn AM, Flood T, Prendiville T, Gennery AR, Leahy TR. Adenosine deaminase deficient SCID with myocardial hypertrophy. J Clin Immunol. 2021;41:1128\u201330.","journal-title":"J Clin Immunol"},{"key":"729_CR58","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","volume":"143","author":"DB Kohn","year":"2019","unstructured":"Kohn DB, Hershfield MS, Puck JM, Aiuti A, Blincoe A, Gaspar HB, et al. Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. J Allergy Clin Immunol. 2019;143:852\u201363.","journal-title":"J Allergy Clin Immunol"},{"key":"729_CR59","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","volume":"384","author":"DB Kohn","year":"2021","unstructured":"Kohn DB, Booth C, Shaw KL, Xu-Bayford J, Garabedian E, Trevisan V, et al. Autologous ex vivo lentiviral gene therapy for adenosine deaminase deficiency. N Engl J Med. 2021;384:2002\u201313.","journal-title":"N Engl J Med"},{"key":"729_CR60","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3389\/fimmu.2019.02406","volume":"10","author":"A Argudo-Ram\u00edrez","year":"2019","unstructured":"Argudo-Ram\u00edrez A, Mart\u00edn-Nalda A, Mar\u00edn-Soria JL, L\u00f3pez-Galera RM, Pajares-Garc\u00eda S, Gonz\u00e1lez de Aledo-Castillo JM, et al. First universal newborn screening program for severe combined immunodeficiency in Europe Two-years experience in Catalonia (Spain). Front Immunol. 2019;10:2406.","journal-title":"Front Immunol"},{"key":"729_CR61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/ijns7030059","volume":"7","author":"C G\u00f6ngrich","year":"2021","unstructured":"G\u00f6ngrich C, Ekwall O, Sundin M, Brodszki N, Fasth A, Marits P, et al. First year of TREC-based national SCID screening in Sweden. Int J Neonatal Screen. 2021;7:59.","journal-title":"Int J Neonatal Screen"},{"key":"729_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jfma.2012.10.020","volume":"114","author":"Y Chien","year":"2015","unstructured":"Chien Y, Chiang S, Chang K, Yu H, Lee W, Tsai L, et al. Incidence of severe combined immunodeficiency through newborn screening in a Chinese population. J Formos Med Assoc. 2015;114:12\u20136.","journal-title":"J Formos Med Assoc"},{"key":"729_CR63","doi-asserted-by":"publisher","first-page":"e20182300","DOI":"10.1542\/peds.2018-2300","volume":"143","author":"GS Amatuni","year":"2019","unstructured":"Amatuni GS, Currier RJ, Church JA, Bishop T, Grimbacher E, Nguyen AA, et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010\u20132017. Pediatrics. 2019;143:e20182300.","journal-title":"Pediatrics"},{"key":"729_CR64","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s10875-018-0550-7","volume":"38","author":"MAP Audrain","year":"2018","unstructured":"Audrain MAP, L\u00e9ger AJC, H\u00e9mont CAF, Miralli\u00e9 SM, Cheillan D, Rimbert MGM, et al. Newborn screening for severe combined immunodeficiency: analytic and clinical performance of the T cell receptor excision circle assay in France (DEPISTREC study). J Clin Immunol. 2018;38:778\u201386.","journal-title":"J Clin Immunol"},{"key":"729_CR65","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13023-021-02130-7","volume":"16","author":"J Guo","year":"2021","unstructured":"Guo J, Liu P, Chen L, Lv H, Li J, Yu W, et al. National rare diseases registry system (NRDRS): China\u2019s first nation-wide rare diseases demographic analyses. Orphanet J Rare Dis. 2021;16:515.","journal-title":"Orphanet J Rare Dis"},{"key":"729_CR66","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1182\/blood.2022016196","volume":"140","author":"GDE Cuvelier","year":"2022","unstructured":"Cuvelier GDE, Logan BR, Prockop SE, Buckley RH, Kuo CY, Griffith LM, et al. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC. Blood. 2022;140:685\u2013705.","journal-title":"Blood"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-023-00729-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-023-00729-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-023-00729-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T16:02:23Z","timestamp":1686499343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-023-00729-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s12519-023-00729-3","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"type":"print","value":"1708-8569"},{"type":"electronic","value":"1867-0687"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Beijing Children\u2019s Hospital, Capital Medical University (2021-E-192-R). Informed consent to participate in the study has been obtained from the participants or their parent or legal guardian in the case of children under 16.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}